The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 13, 2011

Filed:

Mar. 04, 2005
Applicants:

Piet Herdewijn, Wezemaal, BE;

Christophe Pannecouque, Heverlee, BE;

Tongfei Wu, Leuven, BE;

Erik DE Clerq, Bierbeek, BE;

Inventors:

Piet Herdewijn, Wezemaal, BE;

Christophe Pannecouque, Heverlee, BE;

Tongfei Wu, Leuven, BE;

Erik De Clerq, Bierbeek, BE;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/70 (2006.01); A01N 43/04 (2006.01); C07H 15/00 (2006.01); C07H 17/00 (2006.01); C07H 23/00 (2006.01); C07H 19/20 (2006.01); C07H 19/048 (2006.01); C07H 19/16 (2006.01); C07H 19/06 (2006.01);
U.S. Cl.
CPC ...
Abstract

Disclosed herein are novel phosphonate nucleosides and thiophosphonate nucleosides comprising a phosphonalkoxy-substituted or phosphonothioalkyl-substituted five-membered, saturated or unsaturated, oxygen-containing or sulfur-containing ring coupled to a heterocyclic nucleobase such as a pyrimidine or purine base. The invention further relates to compounds having HIV (Human Immunodeficiency Virus) replication inhibiting properties and to compounds having antiviral activities with respect to other viruses. The invention also relates to methods for preparation of all such compounds and pharmaceutical compositions comprising them. The invention further relates to the use of said compounds as a medicine and in the manufacture of a medicament useful for the treatment of subjects suffering from HIV infection, as well as for treatment of other viral, retroviral or lentiviral infections and to the treatment of animals suffering from FIV, viral, retroviral or lentiviral infections.


Find Patent Forward Citations

Loading…